TP53 and cancer: We characterized quantitatively the effect of each missense mutant p53 protein on multiple cancer phenotypes and performed RNA-Seq and ChIP-Seq studies to understand the molecular mechanisms driving the phenotypic differences, with specific focus on the cell invasiveness, the early step of metastasis frequently observed in TNBC.